$VERA

Vera Therapeutics Reports Breakthrough In Iga Nephropathy Treatment

$VERA Vera Therapeutics (NASDAQ:VERA) has recently announced significant progress in its ORIGIN Phase 3 clinical trial, marking a pivotal moment…